



COMMENTARY Year : 2016 | Volume : 7 | Issue : 1 | Page : 1-5

Abuse of topical corticosteroids in India: Concerns and the way forward



Subodh Kumar, Aman Goyal, Yogendra Kumar Gupta

Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India



Date of Web Publication 29-Mar-2016

Correspondence Address:

Yogendra Kumar Gupta

Department of Pharmacology, All India Institute of Medical Sciences, New Delhi

India

Source of Support: None, Conflict of Interest: None Check 11

DOI: 10.4103/0976-500X.179364





How to cite this article:

Kumar S, Goyal A, Gupta YK. Abuse of topical corticosteroids in India: Concerns and the way forward. J Pharmacol Pharmacother 2016;7:1-5

How to cite this URL:

Kumar S, Goyal A, Gupta YK. Abuse of topical corticosteroids in India: Concerns and the way forward. J Pharmacol Pharmacother [serial online] 2016 [cited 2020 Sep 21];7:1-5. Available from: http://www.jpharmacol.com/text.asp?2016/7/1/1/179364

Introduction

Table 1 : List of topical corticosteroids approved in India and their indications[4],[5]



Click here to view

Regulatory Challenges for Topical Corticosteroids in India

Table 2: List of fixed-dose formulations of various topical corticosteroids available in India[7],[8]



Click here to view

Hydroquinone 2% + Tretinoin 0.025% + Hydrocortisone 1%: Treatment of skin hyperpigmentation

Hydroquinone 2% + Tretinoin 0.025% + Mometasone 0.1%: Treatment of moderate to severe melasma of face

Hydroquinone 2% + Tretinoin 0.025% + Fluocinolone 0.015%: Treatment of melasma of face in adults.

Conclusion

References

Tables